Unlike the dual agonist Tirzepatide (GLP-1/GIP) or the mono-agonist Semaglutide (GLP-1), Retatrutide adds glucagon-receptor activation, which in studies is associated with additional increases in energy expenditure, lipolysis and reduced liver fat
Cutaneous fungal infections in eczema: Diagnosis and treatment considerations
Metabolomic profile of response to supplementation with beta-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
Human evidence for precursors is mixed: some trials report good safety, but metabolic endpoints such as insulin sensitivity have not consistently replicated in people
The reality of oral administration for musculoskeletal indications is straightforward: the peptide disperses through the digestive system before it reaches the injury site, and what arrives at a tendon or joint after that journey is a fraction of what a subcutaneous injection placed near the tissue delivers
Nutrition interventions are growing in popularity